Could Twice Yearly Dosing Be Enough? Zumilokibart Data Raise the Bar for AD, 4Could Twice Yearly Dosing Be Enough? Zumilokibart Data Raise the Bar for AD

Summary: A new medicine for severe eczema (atopic dermatitis) called zumilokibart is showing exciting results. Right now, many patients have to take shots every two weeks to keep their skin clear. But in a recent 52-week study, zumilokibart kept patients' skin clear with shots just two to four times a year.

Even better, patients who didn't see quick results at first continued to improve as the year went on. If future tests are successful, this could completely change life for eczema patients—meaning way less "needle fatigue" and a lot more freedom from the doctor's office!

For more details, see rssapp-dermatologytimes-com at dermatologytimes.com/view/could-twice-yearly-dosing-be-enough-zumilokibart-data-raise-the-bar-for-ad (opens in new tab)